The 21 billion euros valuation of Mistral AI is a financial event, yes, but it’s not an approved metric for assessing the regulatory viability of the entire AI Act. We need documented evidence and a clear chain of command for evaluating something so complex, not just one company’s market success. A single fundraising round cannot provide the comprehensive informational context required for such a broad regulatory assessment. For instance, my local health authority wouldn't declare all public health measures successful just because one private hospital received a huge investment; they need audited compliance reports from all clinics, big and small.